Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial

Lancet. 2024 Oct 12;404(10461):1403-1404. doi: 10.1016/S0140-6736(24)01770-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Hepatocellular* / therapy
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / therapy
  • Randomized Controlled Trials as Topic
  • Sorafenib / therapeutic use

Substances

  • Sorafenib